Status:
COMPLETED
D1 vs D2 Lymphadenectomy in Gastric Cancer
Lead Sponsor:
Fundación para la Investigación del Hospital Clínico de Valencia
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study is a retrospective study with a propensity score-matched analysis in order to balance differences between patients with D1 and D2 lymphadenectomy for gastric cancer.The main aim is to analy...
Detailed Description
In this propensity score-matched analysis of 128 patients, D2 lymphadenectomy improved long-term outcomes compared with D1 in patients with curative intent surgery for gastric cancer except for the gr...
Eligibility Criteria
Inclusion
- patients diagnosed with GC stage I-III who underwent a curative gastrectomy +/- perioperative chemotherapy
Exclusion
- patients with adenocarcinoma Siewert type I/II, palliative surgery, R1/R2 resections and pathological stage (pStage) IV.
Key Trial Info
Start Date :
April 1 1990
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
357 Patients enrolled
Trial Details
Trial ID
NCT05253430
Start Date
April 1 1990
End Date
February 1 2021
Last Update
February 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.